Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

In a recent study published in Small, researchers at the University of Michigan developed nanodiscs designed to target ...

Sabrina Lewandowski woke up one morning 23 years ago with a headache that should have killed her. The cause was a stage four ...

Introduction: Glioblastoma (GBM), the most aggressive primary brain tumor, poses a significant challenge in predicting patient survival due to its heterogeneity and resistance to treatment. Accurate ...

Kanazawa University, report in Nature Communications on how the targeted suppression of lysosome function may lead to brain ...

Despite decades of research to develop effective treatments, the median survival for glioblastoma—the most common malignant primary brain tumor in adults—is just 15–18 months after diagnosis.

Brain cancer might not be as prevalent as breast cancer, prostate cancer, or lung cancer, but one type of brain cancer, glioblastoma, comes with a poor prognosis. According to the Mayo Clinic ...

Telix Pharmaceuticals Ltd.’s glioblastoma theranostic, TLX-101, is showing promising overall survival in a phase II trial in ...